Endoscope - Radiofrequency Ablation (RFA) Market by Application (Cardiology, Applications, Pain Management, Oncology Applications, and Other Applications) - Global Opportunity Analysis and Industry Forecast, 2017-2025
- Published Date: 2020-10-18
- Report ID: 3115
- Pages: 75
-
Format:
Endoscopic RFA is an advanced treatment modality, which is commonly applied in the treatment of medical indication such as uncoordinated heartbeats, Barrett's esophagus, and pain management, and others. Radiofrequency ablation is considered to be an FDA-approved advanced endoscopic technique in which the diseased tissue is exposed to heat energy for its destruction or removal. The global endoscope + radiofrequency ablation (RFA) market was valued at $3,567.4 million in 2017 and is estimated to reach at $7,471.5 million by 2025, registering a CAGR of 9.6% from 2018 to 2025.
Upsurge in geriatric population that is highly susceptible to pain and chronic disorders has a positive impact on the market growth. In addition, rise in need for the development of advanced minimally invasive surgical techniques has propelled the demand for endoscopic RFA across healthcare settings, thus fueling the market growth.
However, dearth of skilled professionals that lack complete know-how of endoscopic RFA treatment impedes the market growth. Conversely, high untapped potential in the emerging economies is anticipated to offer significant profitable opportunities for the expansion of the market.
The endoscope + radiofrequency ablation (RFA) market is segmented based on application. On the basis of application, the market is categorized into cardiology applications, pain management, oncology applications, and others.
KEY BENEFITS
This report entails a detailed quantitative analysis of the current market trends from 2017 to 2025 to identify the prevailing opportunities along with strategic assessment of global endoscope + radiofrequency ablation (RFA) market.
Market size and estimations are based on comprehensive analysis of the applications and developments in the industry.
A qualitative analysis based on innovative products and devices facilitate the strategic business planning.
The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.
KEY MARKET SEGMENTS
By Application
Cardiology Applications
Pain Management
Oncology Applications
Other Applications
KEY MARKET PLAYERS
Boston Scientific Corporation
Conmed Corporation
Medtronic Plc.
Smith & Nephew Plc.
Stryker Corporation
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.1.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Endoscope + radiofrequency ablation (RFA) market: Innovative products
3.2.1. Barex 360
3.2.2. Habib EUS RFA catheter
3.2.3. Temperature-resistant probes
3.3. Clinical trials: RFA and RFA + endoscope products in pipeline
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in the prevalence of cancer and cardiac ailments across the globe
3.4.1.2. Large scale adoption of endoscopic RFA devices in pain management
3.4.1.3. High efficacy and short duration of the procedure
3.4.2. Restraints
3.4.2.1. High costs associated with the RFA treatment
3.4.2.2. Limited awareness regarding available RFA + endoscope devices
3.4.3. Opportunity
3.4.3.1. Emerging indications for the endoscopic radiofrequency ablation
CHAPTER 4: ENDOSCOPE + RADIOFREQUENCY ABLATION (RFA) MARKET, BY APPLICATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Oncology application
4.2.1. Market size and forecast
4.3. Pain management
4.3.1. Market size and forecast
4.4. Cardiology application
4.4.1. Market size and forecast
4.5. Other applications
4.5.1. Market size and forecast
CHAPTER 5: COMPANY PROFILES
5.1. Boston Scientific Corporation
5.1.1. Company overview
5.1.2. Company snapshot
5.1.3. Operating business segment
5.1.4. Business performance
5.1.5. Key strategic moves and developments
5.2. Conmed Corporation
5.2.1. Company overview
5.2.2. Company snapshot
5.2.3. Operating business segment
5.2.4. Business performance
5.2.5. Key strategic moves and developments
5.3. Medtronic Plc
5.3.1. Company overview
5.3.2. Company snapshot
5.3.3. Operating business segment
5.3.4. Business performance
5.3.5. Key strategic moves and developments
5.4. Smith & Nephew Plc
5.4.1. Company overview
5.4.2. Company snapshot
5.4.3. Operating business segment
5.4.4. Business performance
5.5. Stryker Corporation
5.5.1. Company overview
5.5.2. Company snapshot
5.5.3. Operating business segments
5.5.4. Business performance
5.5.5. Key strategic moves and developments
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
